Pearl AI Review: Capabilities, FDA Clearance and Cost

Pearl AI is a dental artificial intelligence company whose flagship product, Second Opinion, is FDA-cleared to detect pathologies in dental radiographs in real time. Founded in 2019 by Ophir Tanz and Dr. Kyle Stanley, Pearl positions itself as the broadest dental AI platform currently available — covering radiology, clinical documentation, insurance workflows, and practice analytics under one roof. Whether that breadth is a strength or a complexity risk depends on your practice’s setup.

What Pearl AI Actually Does

The core product is Second Opinion, a computer-vision tool that overlays findings directly on radiographs as clinicians review them. It flags caries, periapical radiolucencies, calculus, restoration margin discrepancies, and a range of non-pathologic landmarks (existing crowns, fillings, implants, bridges). The AI doesn’t make a diagnosis — it highlights areas for clinical review, which is exactly what the FDA clearance covers.

Pearl subsequently received FDA 510(k) clearance for Second Opinion 3D, extending that analysis to cone beam computed tomography (CBCT) scans. Per Dentistry Today’s reporting, this made Pearl the first dental AI company with FDA-cleared solutions for both 2D and 3D radiologic image analysis. A separate clearance for panoramic radiographs followed, covering the most widely used extraoral imaging format in general dentistry.

That’s three distinct FDA clearances. For practices evaluating vendors, the regulatory trail matters: it constrains what claims can be made and sets a bar that not every competitor has cleared.

The Broader Platform

Radiology is where Pearl started, but the company has moved well beyond it.

Practice Intelligence pulls AI findings from X-rays and cross-references them with data from connected practice management systems, giving DSOs and group practices an operational view of undiagnosed conditions, treatment acceptance patterns, and clinical consistency across locations.

Pearl Voice records and transcribes appointments, then converts those interactions into SOAP notes, perio charts, and other structured clinical documentation. Pearl launched this in 2024 — per Dentistry Today — and it’s squarely aimed at reducing the admin burden that erodes clinical time.

Pearl RCM is the company’s revenue cycle management play, connecting eligibility verification, imaging QA, clinical notes, and claim preparation in one pipeline. Precheck handles insurance verification using natural language processing to compile coverage details before the appointment.

Taken together, this is a significant product surface area. A solo practice might use Second Opinion and nothing else. A DSO evaluating enterprise-wide workflow standardization might find Practice Intelligence the more compelling entry point.

FDA Clearance: What It Means in Practice

Pearl’s pearl ai dental clearances are worth unpacking. FDA 510(k) clearance is a predicate-based pathway — it demonstrates substantial equivalence to an already-cleared device, not clinical superiority. That’s the standard mechanism for most dental software cleared as a medical device, and Pearl meeting that bar is meaningful, but it’s not the same as a randomized controlled trial establishing diagnostic benefit.

Pearl’s own data — vendor-reported — claims study participants reading X-rays with Second Opinion identified 36% more lesions than those reading without AI. That’s a notable figure, but it comes from Pearl. Independent peer-reviewed replication of that finding would strengthen the case considerably. It’s worth asking Pearl for study methodology details during a sales conversation.

Market Presence and DSO Adoption

Pearl raised $58 million in funding — described by the British Dental Journal as the largest-ever investment in dental AI — with Left Lane Capital leading and Craft Ventures among returning investors. The American Dental Association also invested in Pearl, per the ADA’s own announcement in December 2024.

On the enterprise side, PDS Health selected Pearl as its AI partner for more than 1,100 practices nationwide, per Dentistry Today. Smile Brands chose Pearl following a multi-vendor evaluation where Pearl, in the vendor’s words, “demonstrated leading clinical performance.” DECA Dental Group is rolling Pearl out across nine states. These are large organizations with procurement processes — their choices provide a useful external signal, even if they’re not independent clinical endorsements.

Pearl’s technology is available in over 500,000 dental practices across six continents, according to company-reported figures, and holds regulatory clearance in more than 120 countries.

Integrations and Workflow Fit

Pearl integrates with dozens of imaging and practice management systems. The native integration with Dentrix Ascend — Henry Schein One’s cloud platform — is notable because it allows AI findings to write directly into the PMS, rather than existing in a separate interface. That’s a real workflow difference. Practices still running server-based systems should verify compatibility before committing.

If you’re comparing Pearl against other radiographic AI vendors, our overjet dental ai comparison breaks down the key differences in approach and feature sets, and our broader dental ai software guide covers what to look for when evaluating any of these platforms.

Cost

Pearl does not publish pricing. Cost depends on practice size, which modules you license, and negotiated contract terms. DSO pricing is separate from individual practice pricing. The safest move is to request a demo, get a written quote, and confirm what integration support is included — some practices have found third-party imaging system connections require additional IT work that isn’t always flagged upfront.

For most general practices, starting with Second Opinion alone — the 2D radiographic tool — makes more sense than adopting the full platform at once. Prove the workflow fit before layering in Pearl Voice, RCM, or Practice Intelligence. The modular structure exists for a reason.